These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15918327)

  • 1. [News in the treatment of hyperphosphatemia].
    Kes P; Baśić-Jukić N
    Lijec Vjesn; 2004; 126(9-10):271-3. PubMed ID: 15918327
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in hyperphosphatemia management.
    Slatopolsky E
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384
    [No Abstract]   [Full Text] [Related]  

  • 3. Resolution of secondary hyperparathyroidism after cadaveric renal allograft.
    Varghese Z; Wills MR; Ahmed KY; Fairney A; Baillod RA; Tatler GL; Hopewell JP; Moorhead JF
    Proc Eur Dial Transplant Assoc; 1975; 11():261-7. PubMed ID: 1105549
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary hyperparathyroidism in chronic renal failure].
    Duric DS; Manojlovic D; Dordevic P
    Acta Med Iugosl; 1972; 26(4):329-38. PubMed ID: 4648015
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
    Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL
    Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.
    Guideline Working Group, Japanese Society for Dialysis Therapy
    Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of phosphate for the development of renal hyperparathyroidism: lessons from a hypophosphataemic patient with nephropathic cystinosis.
    Krmar R; Haffner D; Wühl E; Mehls O
    Nephrol Dial Transplant; 1995 Dec; 10(12):2343-5. PubMed ID: 8808239
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphate is a uremic toxin.
    Burke SK
    J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P
    Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
    [No Abstract]   [Full Text] [Related]  

  • 11. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When is Vitamin D contraindicated in dialysis patients?
    Khosla N; Sprague SM
    Semin Dial; 2009; 22(3):249-51. PubMed ID: 19573002
    [No Abstract]   [Full Text] [Related]  

  • 13. When is Vitamin D Contraindicated in Dialysis Patients?
    Goodman WG
    Semin Dial; 2009; 22(3):245-7. PubMed ID: 19573000
    [No Abstract]   [Full Text] [Related]  

  • 14. When is Vitamin D contraindicated in dialysis patients?
    Martin KJ
    Semin Dial; 2009; 22(3):247-9. PubMed ID: 19573001
    [No Abstract]   [Full Text] [Related]  

  • 15. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral giant cell granuloma associated with hyperparathyroidism secondary to end-stage renal disease: a case report.
    Choi C; Terzian E; Schneider R; Trochesset DA
    J Oral Maxillofac Surg; 2008 May; 66(5):1063-6. PubMed ID: 18423303
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing metastatic calcification in the ESRD patient.
    Harvey KS
    Nephrol News Issues; 1999 Nov; 13(11):54-6, 58. PubMed ID: 10865630
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of phosphate in the genesis of secondary hyperparathyroidism of renal failure.
    Massry SG; Ritz E; Verberckmoes R
    Nephron; 1977; 18(2):77-81. PubMed ID: 854141
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular disease in chronic kidney failure].
    Os I
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1297. PubMed ID: 18546586
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
    Wolf M; Thadhani R
    Semin Dial; 2005; 18(4):302-6. PubMed ID: 16076353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.